GlaucomaCME
LECTURECME

Case-in-Point: Using New Treatments for the Medical Management of Glaucoma

Author(s)/Faculty: Janet B. Serle, MD; Ruth D. Williams, MD
Release Date: 10/19/2018Expiration Date: 10/18/2019
Credit Type: CMENumber of Credits: 0.75
Content Type: LectureProvider:
Glaucoma is the leading cause of irreversible blindness worldwide, with more than 3 million individuals estimated to be affected by the condition in the United States. Early diagnosis and timely initiation of therapy have the potential to provide disease control, but many patients remain at risk for disease progression. Risk of progression may be due to inadequacy of therapy options or lack of patient adherence to therapy protocols, resulting in insufficient control of intraocular pressure (IOP). Recently, the US Food and Drug Administration approved 2 new therapies with novel mechanisms of action for the reduction of IOP. In this educational activity, experts in the field will compare new and emerging medical glaucoma treatments, discuss their mechanisms of action, as well as evaluate the latest clinical evidence for their safety and efficacy. The presentation of case studies will provide clinical guidance for the effective integration of these therapies into protocols for the management of patients with glaucoma.